Kurt Nielsen, Ph.D. shares his strategies for sponsors to extract maximum value from contract service providers, the overlooked benefits of AI, and the shifting dynamics of the global supply chain. Kurt has an extensive background in contract development and manufacturing,
CDMO Live, is the first event of its kind to focus on partnering with the dynamic contract development and manufacturing sector. The fast-paced four hour online event brought together expert insights around critical topics that are shaping the future of
The U.S. House of Representatives has amended the BIOSECURE Act, providing a significant reprieve to WuXi AppTec and other Chinese contract manufacturing organizations (CDMOs). The revised bill now includes an eight-year period of immunity, allowing existing contracts with these entities to continue
This report summarises the key issues impacting prices across a range of categories in the BioPharma industry in April 2024: Biologics contract manufacturing Due to the incoming BIOSECURE Act in the United States, biologics category managers are expected to look
In 2024 the world of Contract Development & Manufacturing has been going through a period of upheaval. Since the start of the year, every day have been significant acquisitions or investments in the CDMO space. In the United States there
BIO) has announced it has “unwavering support” for national security, parting company Wuxi AppTec and WuXi Biologics.
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
